our inception in 1996, Health Sciences Institute has scoured the world to
find cutting-edge treatments few people have access to or have even heard
about. And sometimes, what we uncover startles even the medical mavericks
on our board.
Two months ago, we learned about an astounding cancer-fighting tree from
the Amazon that has literally sent shock waves through the HSI network
Today, the future of cancer treatment and the chances of survival look more
promising than ever. There's a healing tree that grows deep within the Amazon
rain forest in South America that could literally change how you, your doctor,
and possibly the rest of the world think about curing cancer. With extracts
from this powerful tree, it may now be possible to:
Through a series of confidential communications involving a researcher from
one of America's largest pharmaceutical companies, this ancient tree's anticancerous
properties have recently come to light. Although not yet tested in human trials,
the tree has been studied in more than 20 laboratory tests since the 1970s,
where it's been shown to:
- conquer cancer safely and effectively with an all-natural
therapy that doesn't cause extreme nausea, weight loss, and hair loss
- protect your immune system and evade deadly infections
- feel strong and healthy throughout the course of treatment
- boost your energy and improve your outlook on life
So why isn't every health publication extolling the benefits of this treatment?
Why hasn't it been made widely available throughout the natural-medicine community?
And, if it's only half as promising as it appears to be, why isn't every
oncologist at every major hospital insisting on using it on all his patients?
Especially when you consider that since the early 1990s, extensive independent
research-including research by one of today's leading drug companies and
by the National Cancer Institute-confirms that the tree's chemical extracts
attack and destroy cancer cells with lethal precision.
- effectively target and kill malignant cells in 12 different
types of cancer, including colon, breast, prostate, lung, and pancreatic
- be 10,000 times stronger in killing colon cancer cells
than Adriamycin, a commonly used chemotherapeutic drug
- selectively hunt down and kill cancer cells without harming
healthy cells, unlike chemotherapy
The answer to these difficult questions can only be explained by recounting
a disturbing story we recently uncovered. More than anything else we've reported
on this year, the story of this Amazon cancer treatment reinforces the need
for groups like HSI and illustrates how easily our options for medical treatment
are controlled by money and power.
News of this amazing tree was nearly lost forever
A confidential source, whose account we've been able to independently confirm,
revealed that a billion-dollar drug company in the United States tried for
nearly seven years to synthesize two of the tree's most powerful anticancerous
chemicals. In the early 1990s, behind lock and key, this well-known drug giant
began searching for a cure for cancer-while preciously guarding their opportunity
to patent it and, therefore, profit from it.
Research focused on a legendary healing tree called Graviola. Parts of the
tree-including the bark, leaves, roots, fruit, and fruit seeds-had been used
for centuries by medicine men and native Indians in South America to treat
heart disease, asthma, liver problems, and arthritis. Going on little documented
scientific evidence, the company poured money and resources into testing Graviola's
anticancerous properties-and they were shocked by the results. Graviola was
a cancer-killing dynamo. But that's where the story of Graviola nearly ended.
The pharmaceutical company had a big problem. They'd spent years trying
to isolate and create man-made duplicates of two of the tree's most powerful
chemicals. But they'd hit a brick wall. They couldn't replicate the original.
And they couldn't sell the tree extract itself profitably-because federal
law mandates that natural substances can't be patented. That meant the company
couldn't protect its profits on the project it had poured millions of dollars
and nearly seven years of research into.
As the dream of big profits evaporated, testing on Graviola came to a screeching
After seven frustrating years and without the promise of lucrative sales,
the company shelved the project and refused to publish its findings in an
independent journal. But one responsible researcher struggled with the decision.
While understanding the company's goal of profits, he couldn't accept the
decision to hide this unique cancer killer from the world. Following his conscience
and risking his career, he revealed the findings.
It was discovered that several other teams in the United States (in addition
to that of the drug company) had been testing Graviola in vitro (in test
tubes). The results supported the drug company's secret findings; Graviola
had been shown to kill cancer cells.
Health Sciences Institute came across Graviola a few months ago while researching
Chanca Piedra, a natural kidney-stone therapy from the Amazon, that was featured
in our September 2000 issue. And needless to say, our panel of experts were
intrigued by the possibility of this powerful natural cure for cancer.
Graviola hunts down and destroys prostate, lung, breast, colon, and pancreatic
cancers…leaving healthy cells alone
Since November, we've been looking closely into the research to date on
Graviola. It appears one of the first scientific references to it in the
United States was by the National Cancer Institute (NCI). In 1976, the NCI
included Graviola in a plant-screening program that showed its leaves and
stems were effective in attacking and destroying malignant cells. But the
results were part of an internal NCI report and were, for some reason, never
released to the public.1
Since 1976, there have been several promising cancer studies on Graviola.
However, the tree's extracts have yet to be tested on cancer patients. No
double-blind clinical trials exist, and clinical trials are typically the
benchmark mainstream doctors and journals use to judge a treatment's value.
Nevertheless, Graviola has been shown to kill cancer cells in vitro in at
least 20 laboratory tests that our research has uncovered. The most recent
study, conducted at Catholic University of South Korea earlier this year,
revealed that two chemicals extracted from Graviola seeds showed "selective
cytotoxicity comparable with Adriamycin" for breast and colon cancer cells.
The chemicals targeted and killed malignant breast and colon cells in a test
tube-comparable to the commonly used chemotherapy drug Adriamycin.2
Another study, published in the Journal of Natural Products, showed that
Graviola is not only comparable to Adriamycin-but dramatically outperforms
it in laboratory tests. Results showed that one chemical found in Graviola
selectively killed colon cancer cells at "10,000 times the potency of Adriamycin."3
Other promising and ongoing research at Purdue University is supported by
a grant from the National Cancer Institute. Purdue researchers recently found
that leaves from the Graviola tree killed cancer cells "among six human-cell
lines" and were especially effective against prostate and pancreatic cancer
cells.4 In a separate study, Purdue researchers showed that extracts from
the Graviola leaves are extremely effective in isolating and killing lung
Perhaps the most significant result of the study cited above from the Catholic
University of South Korea, and of each of the others we've found, is that
Graviola was shown to selectively target the enemy-leaving all healthy, normal
cells untouched. By comparison, chemotherapy indiscriminately seeks and destroys
all actively reproducing cells-even normal hair and stomach cells. This is
what causes such often-devastating side effects as hair loss and severe nausea.
In this respect, Graviola looks to be a promising alternative or supplement
to mainstream treatments.
Patient reports show Graviola help eliminate tumors
From a clinical standpoint, Graviola still has a long way to go. Its properties
have only been studied in a test tube. That's why it has yet to become widely
known and accepted. The unfortunate truth is that without the promise of huge
revenues from a synthesized, patented drug, it's unlikely that any pharmaceutical
company will invest the hundreds of thousands (even millions) of dollars
it would take to conduct the double-blind, placebo-controlled studies on humans.
This is the underlying challenge to substantiating most nutritional therapies.
Fortunately, Graviola is a natural substance, so we don't have to wait around
for the drug companies. And, thanks to one researcher with a conscience.
Only a relative handful of doctors and patients in the United States
have been using Graviola to fight cancer. Still the combined therapy has
produced some incredible results.
One such case history involved an executive at a high-tech company in Texas.
Daryl S. came across Graviola when exploring alternative treatments to cure
his prostate cancer. A sonogram and biopsy confirmed that Daryl had more than
20 tumors in his prostate. One doctor recommended surgery. But Daryl thought
a cure using this common conventional treatment would come at too great a
cost. He didn't want to suffer from impotence and incontinence for the rest
of his life.
Instead, he agreed to a far less invasive round of hormonal therapy (to
shrink the size of his prostate) and began a rigorous supplement regimen
that centered around Graviola.
Within two months, Daryl's PSA level had dropped from 4.1 to 0.00. A sonogram
and several other gamma-ray tests later confirmed that all the malignant tumors
inside his prostate had disappeared.
Seven years of silence broken
We are continuing to work with others conducting ongoing research on Graviola.
As more scientific and anecdotal evidence comes to light, you'll be among
the first to hear about it. However, after seven years of silence and hidden
research, we felt it irresponsible not to bring this to you now.
Grown and harvested by indigenous people in Brazil, Graviola is available
in limited supply, but now, you can be among a select few in the entire country
to benefit from Graviola. We encourage you, as always, to consult with your
doctor before beginning any new therapy, especially when treating cancer.
You can make tea out of the Graviola leaves, obtain the herb alone in capsule
form as well as in tincture form.
Graviola is completely natural substances with no side effects apart from
possible mild gastrointestinal upset at high dosages (in excess of 5 grams)
if taken on an empty stomach. Despite the mounting collection of laboratory
tests and anecdotal reports about this cancer-fighting dynamo, Graviola may
always remain an underground therapy!
Graviola has yet to be clinically tested on animals or humans. And because
Graviola is a natural product, it can't be patented. Without the promise of
exclusive sales and high profitability, it will likely never again draw the
attention of a major drug company or research lab. So we may never see a
double-blind clinical study on the tree that's reported to help defeat cancer.
But there's no doubt about it-the early laboratory tests and anecdotal reports
about Graviola are very exciting. And if you've been diagnosed with cancer,
you and your doctor should look at all the available treatment options. Graviola
may just provide the help you've been looking for that could make all the
difference in beating cancer.
Unlocking the healing bounty within the Amazon...
The U.S. National Cancer Institute has identified 3,000 plants that are
active against cancer cells--70 percent of which are found in the Amazon
rainforest.1 Until recently, only shaman, healers, and indigenous tribes
held the key to unlocking their extraordinary secrets. Now, thanks to the
unrelenting work of leading nutritional researchers, herbalists, and alternative
doctors like those in the HSI network, the healing secrets of these plants,
such as Graviola, are being uncovered.
Bitter melon (Momordica charantia)
Over the last decade, most of the research on bitter melon has focused on
the vegetable's anti-viral properties. But bitter melon extracts are also
being closely studied for their anticancerous properties.
Five of the plant's phytochemicals have been well documented as having cytotoxic
properties, meaning they've been shown to both kill and inhibit the growth
of cancer cells in vitro. One recent in vitro test conducted by researchers
at Seoul National University studied the cytotoxic effects of 100 plants on
different cell lines in the body. According to their results, the bitter melon
extract showed the "strongest" ability to kill and retard the proliferation
of cancer cells.2
Espinheira Santa (Maytenus illicifolia)
Early scientific research in the 1970s showed that this tree's leaves contain
a unique group of chemicals called maytansinoids that display powerful antitumorous
properties. Although testing on cancer patients revealed some significant
regressions in ovarian carcinoma and some lymphomas, research was discontinued
due to the toxicity reported at high dosages. In the 1990s, scientists isolated
and synthesized a version of the tree's chemicals showing little to no toxicity
to humans. Since then, the tree has been given a second look.
According to one recent study by a research team in Massachusetts, maytansinoid
extracts were found to be "100- to 1,000-fold more cytotoxic than anticancer
drugs currently in clinical use." Specifically, when combined with a special
protein called an antibody that hunts down and kills foreign substances in
the body, this chemical extract was found to be highly cytotoxic toward cultured
colon cancer cells in vitro and showed "remarkable antitumor efficacy in vivo"
(in the body).3
Mullaca (Physalis angulata)
Mullaca's recently identified steroids have garnered the most attention
from the scientific community. In several in vivo animal tests and in vitro
lab tests, Mullaca's steroids demonstrate powerful immune-system support.
Recent cancer studies indicate Mullaca is capable of killing several different
types of malignant cells in vitro. In one study from 1992, Mullaca exhibited
strong cytotoxicity against cancerous kidney cells in a test tube. The plant
extract was also shown to reduce the size of cancerous tumors in mice with
Vassourinha (Scoparia dulcis)
Much of the recent research on Vassourinha has centered around one powerful
phytochemical called scopadulcic acid B (SDB). In a 1993 clinical study, SDB
inhibited the growth of tumors in a test tube and in mice.5 Since the mid-1990s,
scientists have been trying to synthesize several of Vassourinha's phytochemicals,
including SDB, for mainstream use by the pharmaceutical industry.6
Mutamba (Guazuma ulmifolia)
In 1990, a team of Brazilian researchers demonstrated that leaf extracts
from the Mutamba tree inhibited the growth of cancer cells in vitro by 97.3
percent. Some of the latest research on Mutamba has focused on the antioxidants
found in the bark and leaves and their ability to inhibit the growth of bacteria
Suma (Pfaffia paniculata)
Recent studies on Suma's anticancerous properties look particularly promising.
Two of Suma's phytochemicals have been shown to inhibit the growth of tumor
cells in vitro, and in the year 2000 a Japanese team of researchers demonstrated
that Suma inhibited lymphomas and leukemia in mice.
Cat's Claw (Uncaria tomentosa)
Recent studies indicate that at least six of the Cat's Claw vine's alkaloids
can increase the functioning of the immune system by up to 50 percent. This
has led to its use around the world by cancer and AIDS patients. Cancer patients
who take Cat's Claw in conjunction with traditional cancer therapies have
reported fewer side effects than typically associated with chemotherapy and
radiation, such as hair loss, weight loss, nausea, secondary infections, and
skin problems. Additionally, five of the vine's alkaloids have been shown
to inhibit the growth of lymphoma and leukemic cells in vitro.7
Used for centuries by South American medicine men, Graviola and these other
botanicals from the Amazon have only recently begun to reveal their secrets
in rigorous scientific tests. And their cancer-fighting potential is undeniable.
Furthermore, these extraordinary botanicals actually boost your immune system,
instead of destroying it, as chemotherapy does.
Supplement to article
Graviola fights more than cancer
While the research on Graviola has focused on its cancer-fighting effect,
the plant has been used for centuries by medicine men in South America to
treat an astonishing number of ailments, including:
hypertension, influenza, rashes, neuralgia, arthritis, rheumatism, high blood pressure, diarrhea, nausea, dyspepsia, ulcers, ringworm, scurvy, malaria, dysentery, palpitations, nervousness, insomnia, fever, boils, muscle spasm.
For more information visit the Health Science Institute web site and search Graviola.